Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances hiv infection of langerhans cells

Cell Host and Microbe

Volumn 13, Issue 1, 2013, Pages 77-86

  Ogawa, Youichi ^a   Kawamura, Tatsuyoshi ^a   Matsuzawa, Takamitsu ^a   Aoki, Rui ^a   Gee, Peter ^c   Yamashita, Atsuya ^a   Moriishi, Kohji ^a   Yamasaki, Kenshi ^b   Koyanagi, Yoshio ^c   Blauvelt, Andrew ^d   Shimada, Shinji ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d OREGON MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; KERATINOCYTE; LANGERHANS CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SEXUAL TRANSMISSION; SUPERNATANT; VIRUS TRANSMISSION;

HUMAN HERPESVIRUS 2;

EID: 84872572215     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2012.12.002     Document Type: Article

References (52)

1. B. Auvert, D. Taljaard, E. Lagarde, J. Sobngwi-Tambekou, R. Sitta, and A. Puren Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial PLoS Med. 2 2005 e298 10.1371/journal.pmed.0020298
2. R.C. Bailey, S. Moses, C.B. Parker, K. Agot, I. Maclean, J.N. Krieger, C.F. Williams, R.T. Campbell, and J.O. Ndinya-Achola Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial Lancet 369 2007 643 656
3. P. Bergman, L. Walter-Jallow, K. Broliden, B. Agerberth, and J. Söderlund The antimicrobial peptide LL-37 inhibits HIV-1 replication Curr. HIV Res. 5 2007 410 415
4. D.W. Cameron, J.N. Simonsen, L.J. D'Costa, A.R. Ronald, G.M. Maitha, M.N. Gakinya, M. Cheang, J.O. Ndinya-Achola, P. Piot, and R.C. Brunham Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men Lancet 2 1989 403 407
5. A.L. Cunningham, R.R. Turner, A.C. Miller, M.F. Para, and T.C. Merigan Evolution of recurrent herpes simplex lesions. An immunohistologic study J. Clin. Invest. 75 1985 226 233
6. M.A. de Jong, L. de Witte, M.J. Oudhoff, S.I. Gringhuis, P. Gallay, and T.B. Geijtenbeek TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo J. Clin. Invest. 118 2008 3440 3452
7. M.A. de Jong, L. de Witte, M.E. Taylor, and T.B. Geijtenbeek Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function J. Immunol. 185 2010 1633 1641
8. L. de Witte, A. Nabatov, M. Pion, D. Fluitsma, M.A. de Jong, T. de Gruijl, V. Piguet, Y. van Kooyk, and T.B. Geijtenbeek Langerin is a natural barrier to HIV-1 transmission by Langerhans cells Nat. Med. 13 2007 367 371
9. K.M. Fahrbach, S.M. Barry, M.R. Anderson, and T.J. Hope Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin's role in HIV transmission Mucosal Immunol. 3 2010 410 418
10. D.T. Fleming, and J.N. Wasserheit From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection Sex. Transm. Infect. 75 1999 3 17
11. S.R. Galvin, and M.S. Cohen The role of sexually transmitted diseases in HIV transmission Nat. Rev. Microbiol. 2 2004 33 42
12. Y. Ganor, Z. Zhou, D. Tudor, A. Schmitt, M.C. Vacher-Lavenu, L. Gibault, N. Thiounn, J. Tomasini, J.P. Wolf, and M. Bomsel Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates Mucosal Immunol. 3 2010 506 522
13. R.H. Gray, G. Kigozi, D. Serwadda, F. Makumbi, S. Watya, F. Nalugoda, N. Kiwanuka, L.H. Moulton, M.A. Chaudhary, and M.Z. Chen Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial Lancet 369 2007 657 666
14. S.I. Gringhuis, M. van der Vlist, L.M. van den Berg, J. den Dunnen, M. Litjens, and T.B. Geijtenbeek HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells Nat. Immunol. 11 2010 419 426
15. J.C. Grivel, R.J. Shattock, and L.B. Margolis Selective transmission of R5 HIV-1 variants: where is the gatekeeper? J. Transl. Med. 9 Suppl 1 2011 S6
16. A.T. Haase Targeting early infection to prevent HIV-1 mucosal transmission Nature 464 2010 217 223
17. K. Hrecka, C. Hao, M. Gierszewska, S.K. Swanson, M. Kesik-Brodacka, S. Srivastava, L. Florens, M.P. Washburn, and J. Skowronski Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein Nature 474 2011 658 661
18. J. Hu, M.B. Gardner, and C.J. Miller Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells J. Virol. 74 2000 6087 6095
19. T. Kawamura, S.S. Cohen, D.L. Borris, E.A. Aquilino, S. Glushakova, L.B. Margolis, J.M. Orenstein, R.E. Offord, A.R. Neurath, and A. Blauvelt Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants J. Exp. Med. 192 2000 1491 1500
20. T. Kawamura, M. Qualbani, E.K. Thomas, J.M. Orenstein, and A. Blauvelt Low levels of productive HIV infection in Langerhans cell-like dendritic cells differentiated in the presence of TGF-beta1 and increased viral replication with CD40 ligand-induced maturation Eur. J. Immunol. 31 2001 360 368
21. T. Kawamura, F.O. Gulden, M. Sugaya, D.T. McNamara, D.L. Borris, M.M. Lederman, J.M. Orenstein, P.A. Zimmerman, and A. Blauvelt R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms Proc. Natl. Acad. Sci. USA 100 2003 8401 8406
22. T. Kawamura, S.E. Kurtz, A. Blauvelt, and S. Shimada The role of Langerhans cells in the sexual transmission of HIV J. Dermatol. Sci. 40 2005 147 155
23. T. Kawamura, Y. Koyanagi, Y. Nakamura, Y. Ogawa, A. Yamashita, T. Iwamoto, M. Ito, A. Blauvelt, and S. Shimada Significant virus replication in Langerhans cells following application of HIV to abraded skin: relevance to occupational transmission of HIV J. Immunol. 180 2008 3297 3304
24. M.E. Klotman, and T.L. Chang Defensins in innate antiviral immunity Nat. Rev. Immunol. 6 2006 447 456
25. M.E. Klotman, A. Rapista, N. Teleshova, A. Micsenyi, G.A. Jarvis, W. Lu, E. Porter, and T.L. Chang Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission J. Immunol. 180 2008 6176 6185
26. Y. Koyanagi, Y. Tanaka, J. Kira, M. Ito, K. Hioki, N. Misawa, Y. Kawano, K. Yamasaki, R. Tanaka, and Y. Suzuki Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain J. Virol. 71 1997 2417 2424
27. N. Laguette, B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, and M. Benkirane SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx Nature 474 2011 654 657
28. M.M. Lederman, R.S. Veazey, R. Offord, D.E. Mosier, J. Dufour, M. Mefford, M. Piatak Jr., J.D. Lifson, J.R. Salkowitz, and B. Rodriguez Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 Science 306 2004 485 487
29. M.M. Lederman, R.E. Offord, and O. Hartley Microbicides and other topical strategies to prevent vaginal transmission of HIV Nat. Rev. Immunol. 6 2006 371 382
30. P. Levinson, R. Kaul, J. Kimani, E. Ngugi, S. Moses, K.S. MacDonald, K. Broliden, T. Hirbod Kibera HIV Study Group Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition AIDS 23 2009 309 317
31. R. Liu, W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup, and N.R. Landau Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 1996 367 377
32. C.J. Miller, S.L. Johnson, T.R. Kwapil, and C.S. Carver Three studies on self-report scales to detect bipolar disorder J. Affect. Disord. 128 2011 199 210
33. C.J. Miller, A.L. Rose, and T.D. Waite Phthalhydrazide chemiluminescence method for determination of hydroxyl radical production: modifications and adaptations for use in natural systems Anal. Chem. 83 2011 261 268
34. S. Morizane, K. Yamasaki, F.D. Kabigting, and R.L. Gallo Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid J. Invest. Dermatol. 130 2010 1297 1306
35. Y. Ogawa, T. Kawamura, T. Kimura, M. Ito, A. Blauvelt, and S. Shimada Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation Blood 113 2009 5157 5166
36. P.Y. Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R.L. Gallo, and D.Y. Leung Endogenous antimicrobial peptides and skin infections in atopic dermatitis N. Engl. J. Med. 347 2002 1151 1160
37. M. Pion, A. Granelli-Piperno, B. Mangeat, R. Stalder, R. Correa, R.M. Steinman, and V. Piguet APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection J. Exp. Med. 203 2006 2887 2893
38. M.E. Quiñones-Mateu, M.M. Lederman, Z. Feng, B. Chakraborty, J. Weber, H.R. Rangel, M.L. Marotta, M. Mirza, B. Jiang, and P. Kiser Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication AIDS 17 2003 F39 F48
39. J.C. Reece, A.J. Handley, E.J. Anstee, W.A. Morrison, S.M. Crowe, and P.U. Cameron HIV-1 selection by epidermal dendritic cells during transmission across human skin J. Exp. Med. 187 1998 1623 1631
40. K. Sato, J. Aoki, N. Misawa, E. Daikoku, K. Sano, Y. Tanaka, and Y. Koyanagi Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins J. Virol. 82 2008 1021 1033
41. R.J. Shattock, and J.P. Moore Inhibiting sexual transmission of HIV-1 infection Nat. Rev. Microbiol. 1 2003 25 34
42. A.I. Spira, P.A. Marx, B.K. Patterson, J. Mahoney, R.A. Koup, S.M. Wolinsky, and D.D. Ho Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques J. Exp. Med. 183 1996 215 225
43. L. Sun, C.M. Finnegan, T. Kish-Catalone, R. Blumenthal, P. Garzino-Demo, G.M. La Terra Maggiore, S. Berrone, C. Kleinman, Z. Wu, and S. Abdelwahab Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection J. Virol. 79 2005 14318 14329
44. T.S. Theodore, G. Englund, A. Buckler-White, C.E. Buckler, M.A. Martin, and K.W. Peden Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions AIDS Res. Hum. Retroviruses 12 1996 191 194
45. A. Wald, and K. Link Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis J. Infect. Dis. 185 2002 45 52
46. K. Yamasaki, J. Schauber, A. Coda, H. Lin, R.A. Dorschner, N.M. Schechter, C. Bonnart, P. Descargues, A. Hovnanian, and R.L. Gallo Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin FASEB J. 20 2006 2068 2080
47. K. Yamasaki, A. Di Nardo, A. Bardan, M. Murakami, T. Ohtake, A. Coda, R.A. Dorschner, C. Bonnart, P. Descargues, and A. Hovnanian Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea Nat. Med. 13 2007 975 980
48. M. Zaitseva, A. Blauvelt, S. Lee, C.K. Lapham, V. Klaus-Kovtun, H. Mostowski, J. Manischewitz, and H. Golding Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection Nat. Med. 3 1997 1369 1375
49. Z.Q. Zhang, T. Schuler, W. Cavert, D.W. Notermans, K. Gebhard, K. Henry, D.V. Havlir, H.F. Günthard, J.K. Wong, and S. Little Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection Proc. Natl. Acad. Sci. USA 96 1999 5169 5172
50. Z. Zhou, N. Barry de Longchamps, A. Schmitt, M. Zerbib, M.C. Vacher-Lavenu, M. Bomsel, and Y. Ganor HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells PLoS Pathog. 7 2011 e1002100 10.1371/journal.ppat.1002100
51. T. Zhu, H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup, and D.D. Ho Genotypic and phenotypic characterization of HIV-1 patients with primary infection Science 261 1993 1179 1181
52. J. Zhu, F. Hladik, A. Woodward, A. Klock, T. Peng, C. Johnston, M. Remington, A. Magaret, D.M. Koelle, A. Wald, and L. Corey Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition Nat. Med. 15 2009 886 892